An integrated platform combining high-performance computing infrastructure with proprietary AI models purpose-built for biological data — from target identification to lead optimization.
Each capability is built on a foundation of proprietary data assets and custom-trained models, delivered as tailored solutions for each enterprise partner.
Deep learning models trained on multi-omic datasets surface high-confidence therapeutic targets with speed and precision, significantly reducing the early-discovery timeline. Our models integrate genomic, transcriptomic, and proteomic evidence layers to prioritize targets with the strongest disease association signals.
Advanced generative models and molecular simulation capabilities for designing and optimizing biologic candidates with desired binding affinity, stability, and developability profiles. We leverage diffusion-based and language-model approaches to explore the vast sequence-structure landscape.
Scalable pipelines for processing and integrating genomics, transcriptomics, proteomics, and metabolomics data to uncover mechanistic insights and biomarker signatures. Our infrastructure handles petabyte-scale datasets with automated quality control and normalization.
Purpose-built training and inference clusters optimized for large-scale biological foundation models. Our dedicated GPU infrastructure delivers the computational throughput required for enterprise-grade AI workloads — from pre-training to fine-tuning and high-throughput inference.
Physics-informed AI models for high-throughput virtual screening, binding affinity prediction, and molecular dynamics simulations. Our hybrid approach combines classical force-field methods with learned potentials for accuracy at scale.
Each partner engagement begins with understanding your specific research goals. We architect bespoke computational workflows that integrate with your existing data infrastructure and R&D processes, ensuring seamless adoption and maximum impact.
From raw biological data to optimized therapeutic candidates — our integrated pipeline accelerates every stage of the discovery process.
Our AI models are trained on curated, high-quality biological datasets spanning multiple modalities — combined with each partner's proprietary data under strict security protocols.